News

Proteomics International Inks Israeli Distribution Deal for Diabetic Kidney Disease Immunoassay – 360Dx

We believe entering both the European and Middle Eastern markets in recent weeks will drive demand for PromarkerD in 2021 and beyond,” said Richard Lipscombe, managing director of Perth, Australia-based Proteomics International, in a statement.

Article: Proteomics International Inks Israeli Distribution Deal for Diabetic Kidney Disease Immunoassay

Subscribe
  • This field is for validation purposes and should be left unchanged.